The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2019 | Induction in myeloma: a journey over time
Induction therapy regimens prior to transplant in multiple myeloma have changed significantly over the past several decades, as explained by Mohamad Mohty, MD, PhD, of Saint-Antoine Hospital, Paris, France. Prof. Mohty gives us his insight into this change and where we may be going next. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.
